Tuesday, September 25, 2018 12:41:14 PM
Sent From: "Timothy Carnahan" <carnahan@cyios.com>
Sent To: kingdr@sec.gov
Subject: Fwd: Letter of Cancellation (see attached)
David,
Hope your investigation has some substantial reasoning --- it is the direct cause of this letter.
Tim:
Timothy W. Carnahan
CEO
2023691984
CYIOS Corporation
Ronald Reagan Building
1300 Pennsylvania Ave,700
Washington,20004
powered by www.cyipro.com
We had been told from the merger group that they could not merge due to an SEC investigation;
Mr. King leading the investigation had communications with a third party about CYIOS
Corporation thus leading to a cancellation of the merger.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM